About
Kevin McBribe is a General Partner and Chief Scientific Officer at AmorChem Ventures and CEO at ARNA Therapeutics. He has held positions in academic research, biotech drug discovery and development, and business development, with experience working alongside venture capital investors. He has served as a science representative at the board level for multiple organizations.
Experience
- TiimeCo-founder and CEOcurrent2015 β presentwww.tiime.org
- InnpactIndependent Board Directorcurrent2024 β present
- ToniicBoard Membercurrent2022 β present
- Ruth Asset ManagementIndependent Board Directorcurrent2024 β present
- Luxembourg Earth Investment Fund (LEIF)Independent Board Directorcurrent2022 β present
- Heading for ChangeGlobal Stewardship Councilcurrent2023 β present
- Criterion InstituteShift Narratives in Innovative Finance Advisory Boardcurrent2023 β present
- EQT GroupImpact Advisorcurrent2021 β present
- EQT GroupImpact Director, Mission Board to the EQT Future Fund2021 β 2025
- Ananda Impact VenturesVenture Partnercurrent2020 β presentMunich
- Regeneration GroupBoard Membercurrent2020 β present
- INSEADAdjunct Professorcurrent2019 β present
- University of LuxembourgAdjunct Professor and Guest Lecturer (Wealth Management and SESI)current2012 β present
- Luxembourg Sustainable Finance InitiativeVice Chair IIAB (Impact Investing Advisory Board)current2021 β presentLuxembourg
- Mobius Capital PartnersBoard Member (Independent Director)2018 β 2025
- Proxy PBoard Member2021 β 2024
- Subnational Climate Finance initiative (SCF)Independent Board Director2021 β 2023USA/Luxembourg
- GenderSmartAdvisory Council2017 β 2022London, England, United Kingdom
- Conseil Superieur pour un Development Durable (CSDD)Advisor to the Luxembourg Government on Sustainable Development2016 β 2022Luxembourg
- Sacred Heart University Luxembourg, Jack Welch College of BusinessAdjunct Professor of Entrepreneurship & Social Entrepreneurship / Impact Economy2006 β 2022
- University of EssexExecutive Fellow2014 β 2021https://www.essex.ac.uk/ebs/business/executive-fellows/
Skills & more
Strategy99Strategic Planning34Management82Negotiation33Public Speaking5ModeratingTraining6Management Consulting42Entrepreneurship99Start-ups99Business Development84Business Strategy73
+12 more
Change ManagementMergers & AcquisitionsSocial EntrepreneurshipProject ManagementProgram ManagementInvestmentsMarketingBusiness PlanningPublic RelationsBusiness AnalysisVenture CapitalInternational BusinessLanguages French Β· German Β· Swedish
From Kevin's professional profile.
Colleagues at AmorChem
Frequently asked questions
- Who is Kevin McBribe?
- Kevin McBribe is a General Partner and Chief Scientific Officer at AmorChem Ventures and CEO at ARNA Therapeutics. He has held positions in academic research, biotech drug discovery and development, and business development, with experience working alongside venture capital investors. He has served as a science representative at the board level for multiple organizations.
- Where does Kevin McBribe work?
- Kevin McBribe is Partner at AmorChem.
- What check size does Kevin McBribe write?
- Kevin McBribe typically writes checks of $100K β $5M.
- Where did Kevin McBribe go to school?
- Kevin McBribe studied at Brown University (BA, International Relations); Copenhagen Business School (MBA); Lund University (Masters, Political Science & Economics - focus Asia).
Same school
Also attended Brown University536
Theresia GouwFounding Partner at Acrew CapitalJoe GebbiaCo-founder of AirbnbDylan FieldCo-founder, CEO & Chair of FigmaAli Fisher SweetInvestor at Index VenturesMark GoldbergInvestor at Index VenturesKarim FarisInvestor at GV (Google Ventures)
+ 530 more
Also attended Copenhagen Business School418
Jeppe RindomCo-founder & CEO of PleoJavier SuarezCo-founder & CEO of Oliva; co-founder of PerkLinaInvestor at InvestinorJonathan W.Deeptech Fellow at Clear VenturesAntonio GrifoniAssociate at P101 VenturesThomas JuvinManaging Director Europe at Burda Principal Investments
+ 412 more
Also attended Lund University108
Chen Yang SiaGeneral Counsel at Golden Gate VenturesChen YangAdvisor at Golden Gate VenturesChristian NagelInvestor at Earlybird Venture CapitalAlexander Fred-OjalaInvestor at EQT VenturesChloe ParamattiInvestor at EQT VenturesRony Patishi-ChillimInvestor at Israel Cleantech Ventures
+ 102 more
Shared employers
Also worked at Ananda Impact Ventures10
Mascha BonkSenior Associate at Hitachi VenturesJohannes WeberGeneral Partner and Founder at Ananda Impact VenturesZoe PedenPartner at Ananda Impact VenturesVictor SzaboInvestment Manager at Ananda Impact VenturesLarry AschebrookManaging Partner at G SquaredJohn MillerAnalyst at KOMPAS VC
+ 4 more











































